Oxford Immunotec Global PLC EV/Sales
What is the EV/Sales of Oxford Immunotec Global PLC?
The EV/Sales of Oxford Immunotec Global PLC is 5.21
What is the definition of EV/Sales?
Enterprise value to sales ratio compares a company’s total value to its sales.
ttm (trailing twelve months)
Enterprise value/sales is a valuation ratio that compares the company's enterprise value to its annual sales. It indicates the company's capacity to generate free cash flow. In general, the lower the ratio, the cheaper the company is.
EV/Sales is most often calculated as cash and cash equivalents subtracted from the sum of market capitalization and debt and divided by annual sales. Many analysts consider EV/sales to be a more accurate metric than Price/Sales as it considers both debt and equity holders in its calculation. One of the limitations of the calculation is that sales do not take into account a company's taxes or expenses.
EV/Sales of companies in the Health Care sector on NASDAQ compared to Oxford Immunotec Global PLC
Companies with ev/sales similar to Oxford Immunotec Global PLC
- Wave Life Sciences has EV/Sales of 5.21
- Kerry Properties has EV/Sales of 5.21
- Megaport has EV/Sales of 5.21
- Allied Esports Entertainment has EV/Sales of 5.21
- Astra Microwave Products has EV/Sales of 5.21
- Circassia Pharmaceuticals Plc has EV/Sales of 5.21
- Oxford Immunotec Global PLC has EV/Sales of 5.21
- Indiabulls Integrated Services has EV/Sales of 5.22
- ABB India has EV/Sales of 5.22
- ReTo Eco-Solutions Inc has EV/Sales of 5.22
- BlackLine Inc has EV/Sales of 5.22
- Linde Plc has EV/Sales of 5.23
- AstraZeneca Plc has EV/Sales of 5.23